Author’s reply to “Antiarrhythmic drug use after catheter ablation of atrial fibrillation”

Read full text Summarise with VIRAT
Authors: Jacob R. Heath, Peter D Farjo, Paari S. Dominic
Cited by: 0
References: 3

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We thank Lenormand et. al. for their insightful comments related to our manuscript.1 In our original manuscript, we showed that atrial fibrillation (AF) recurrence (defined as cardioversion, re-ablation, or AAD use) after catheter ablation (CA) was less likely after a diagnosis to ablation time (DAT)1 year at 5-years (aOR 0.68 [0.64–0.72]; p

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments Cardiac electrophysiology and arrhythmias

Publication details

Journal / source
Heart Rhythm O2
Volume
7
Issue
6
Pages
1201–1201
Publication date
26 March 2026
Language
EN